Day One Announces Updated FIREFLY-1 Data for Tovorafenib
Today, Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling New Drug Application (NDA) submission to U.S. Food and Drug Administration (FDA) for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG). Read more
HERE.

By Kelly Barch, Executive Director of the Lilabean Foundation
•
July 29, 2026
Thirteen years ago, my dad passed away from cancer. Long before that, he'd spent years at Herson's Honda teaching sales after starting his second career. When I was old enough to drive, my very first car was a Honda Civic from that same lot.


